Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
30.89
+1.16 (3.90%)
Mar 14, 2025, 11:29 AM EDT - Market open

Viking Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
3,4674,4841,862721360411
Upgrade
Market Cap Growth
140.89%140.89%158.23%100.31%-12.38%-29.13%
Upgrade
Enterprise Value
2,4363,5551,487567144156
Upgrade
Last Close Price
29.7340.2418.619.404.605.63
Upgrade
PB Ratio
3.775.095.344.961.781.68
Upgrade
P/TBV Ratio
5.095.095.344.961.781.68
Upgrade
Debt / Equity Ratio
0.000.000.000.010.000.00
Upgrade
Quick Ratio
32.9332.9318.927.0823.0220.48
Upgrade
Current Ratio
33.0933.0919.197.6123.9821.12
Upgrade
Return on Equity (ROE)
-17.90%-17.90%-34.79%-39.67%-24.65%-15.15%
Upgrade
Return on Assets (ROA)
-14.78%-14.78%-23.47%-23.19%-14.90%-9.86%
Upgrade
Return on Capital (ROIC)
-15.32%-15.32%-25.38%-25.21%-15.58%-10.21%
Upgrade
Earnings Yield
-3.30%-2.45%-4.61%-9.55%-15.28%-9.62%
Upgrade
FCF Yield
-2.63%-1.96%-3.94%-6.71%-13.22%-5.30%
Upgrade
Buyback Yield / Dilution
-15.57%-15.57%-22.79%0.47%-6.34%-0.89%
Upgrade
Total Shareholder Return
-15.57%-15.57%-22.79%0.47%-6.34%-0.89%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.